Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MMP1 | P03956 | 9/20 | 0.44 |
| ▸ | MMP2 | P08253 | 9/20 | 0.44 |
| ▸ | MMP9 | P14780 | 9/20 | 0.44 |
| ▸ | EGFR | P00533 | 8/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4774480 | 1.00 | TRPV1 (0.50) | TRPV1MAPTSMN1; SMN2MEN1NPC1 | |
| SCHEMBL4773020 | 0.94 | TRPV1 (0.53) | TRPV1MAPTSMN1; SMN2MEN1NPC1 | |
| SCHEMBL4773031 | 0.94 | TRPV1 (0.53) | TRPV1MAPTSMN1; SMN2MEN1NPC1 | |
| Trifluoroacetic Acid SCHEMBL4768005 | 0.93 | TRPV1 (0.51) | TRPV1MAPTSMN1; SMN2MEN1NPC1 | |
| Trifluoroacetic Acid SCHEMBL4767993 | 0.93 | TRPV1 (0.51) | TRPV1MAPTSMN1; SMN2MEN1NPC1 | |
| Trifluoroacetic Acid SCHEMBL4770275 | 0.92 | IMPDH2 (0.52) | TRPV1MAPTSMN1; SMN2MEN1NPC1 | |
| Trifluoroacetic Acid SCHEMBL4770261 | 0.92 | IMPDH2 (0.52) | TRPV1MAPTSMN1; SMN2MEN1NPC1 | |
| Trifluoroacetic Acid SCHEMBL4765269 | 0.89 | MAPT (0.51) | TRPV1MAPTSMN1; SMN2MEN1NPC1 | |
| Trifluoroacetic Acid SCHEMBL4766896 | 0.89 | MAPT (0.51) | TRPV1MAPTSMN1; SMN2MEN1NPC1 | |
| Trifluoroacetic Acid SCHEMBL4774201 | 0.89 | MAPT (0.48) | TRPV1MAPTSMN1; SMN2MEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1713778-B1 | BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS | GLAXO GROUP LTD (GB) | 2008-01-16 | — | — | EP | claimed |
| US-20070060566-A1 | Benzazepine derivatives as histamine h3 antagonists | GLAXO GROUP LIMITED (GB) | 2007-03-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060566-A1 | Benzazepine derivatives as histamine h3 antagonists | HRH3, HRH4, HRH1 | TRPV1 125/4885MAPT 405/4885SMN1; SMN2 2487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.